Patient selection for left ventricular assist devices

European Journal of Heart Failure

Volumn 12, Issue 5, 2010, Pages 434-443

  Lund, Lars H ^a   Matthews, Jennifer ^b   Aaronson, Keith ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Advanced heart failure; Heart transplantation; Left ventricular assist device; Mechanical circulatory support; Patient selection

Indexed keywords

CARDIOVASCULAR RISK; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; DEFIBRILLATOR; HEALTH SURVEY; HEART ASSIST DEVICE; HEART VENTRICLE; INNERVATION; RISK ASSESSMENT; TIME;

DEFIBRILLATORS, IMPLANTABLE; HEALTH STATUS INDICATORS; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; TIME FACTORS;

EID: 77958617023     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq006     Document Type: Review

References (104)

1. Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004;88:1321-1345, xii. (Pubitemid 39178141)
2. Deng MC. Orthotopic heart transplantation: highlights and limitations. Surg Clin North Am 2004;84:243-255. (Pubitemid 38232670)
3. Warner-Stevenson L. The evolving role of mechanical circulatory support in advanced heart failure. In: Frazier O, Kirklin J (eds), ISHLT Monograph Series 1, Mechanical Circulatory Support. Elsevier Inc; 2006. p181-203.
4. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505. (Pubitemid 47450258)
5. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for endstage heart failure. N Engl J Med 2001;345:1435-1443.
6. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007;50:741-747. (Pubitemid 47239315)
7. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007;26:769-781. (Pubitemid 47199081)
8. Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail 2008;14:316-321.
9. http://www.thoratec.com/medical-professionals/vad-product-information/ heartmate-ll-lvad.aspx (26 October 2009).
10. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, Rodeheffer RJ. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115:1563-1570. (Pubitemid 46648641)
11. Baughman KL, Jarcho JA. Bridge to life-cardiac mechanical support. N Engl J Med 2007;357:846-849.
12. Hutchinson J, Scott DA, Clegg AJ, Loveman E, Royle P, Bryant J, Colquitt JL. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Expert Rev Cardiovasc Ther 2008;6:175-185. (Pubitemid 351372585)
13. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
14. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479.
15. Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg 2003;75(Suppl. 6): S29-S35. (Pubitemid 36677187)
16. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation 2005;112:e111-e115.
17. Potapov EV, Loforte A, Weng Y, Jurmann M, Pasic M, Drews T, Loebe M, Hennig E, Krabatsch T, Koster A, Lehmkuhl HB, Hetzer R. Experience with over 1000 implanted ventricular assist devices. J Card Surg 2008;23:185-194. (Pubitemid 351589424)
18. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-1533. (Pubitemid 28543502)
19. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, Naftel DC, Kirklin JK, Taylor DO. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 2005;24:1182-1187. (Pubitemid 41247796)
20. INTERMACS. http://www.uab.edu/ctsresearch/intermacs/statisticalsummaries. htm (26 October 2009).
21. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-1884. (Pubitemid 44664645)
22. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-2389. (Pubitemid 28549781)
23. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115:2497-2505. (Pubitemid 46763223)
24. Liden H, Karason K, Bergh CH, Nilsson F, Koul B, Wiklund L. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Eur J Heart Fail 2007;9:525-530. (Pubitemid 46562590)
25. Lund LH, Aaronson KD, Mancini DM. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol 2005;95:734-741. (Pubitemid 40332651)
26. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006;25:1024-1042. (Pubitemid 44311532)
27. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
28. Esmore D, Kaye D, Spratt P, Larbalestier R, Ruygrok P, Tsui S, Meyers D, Fiane AE, Woodard J. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008;27:579-588.
29. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186-1195.
30. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-896. (Pubitemid 47347322)
31. Navia J. Mechanical circulatory support. In: McCarthy P, Young J (eds), Heart Failure: A Combined Medical and Surgical Approach. Malden, MA: Blackwell Futura; 2007. 380 pp, ISBN: 978-1-4051-2203-0.
32. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008;118(Suppl. 14): S94-S105.
33. Gronda E, Bourge RC, Costanzo MR, Deng M, Mancini D, Martinelli L, Torre-Amione G, O'Hara ML, Chambers S. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006;25:1043-1056. (Pubitemid 44376580)
34. Kamiya H, Koch A, Sack FU, Akhyari P, Remppis A, Dengler TJ, Karck M, Lichtenberg A. Who needs 'bridge' to transplantation in the presence of the Eurotransplant high-urgency heart transplantation program? Eur J Cardiothorac Surg 2008;34:1129-1133. Discussion 1134-1125.
35. Stewart GC, Brooks K, Pratibhu PP, Tsang SW, Semigran MJ, Smith CM, Saniuk C, Camuso JM, Fang JC, Mudge GH, Couper GS, Baughman KL, Stevenson LW. Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transplant 2009;28:863-869.
36. Williams M, Casher J, Joshi N, Hankinson T, Warren M, Oz M, Naka Y, Mancini D. Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? J Thorac Cardiovasc Surg 2003;126:436-441. (Pubitemid 37048509)
37. INTERMACS. http://www.intermacs.org (07 September 2009).
38. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535-541.
39. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, Kayne HL, Poirier VL, Dasse KA. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-336. Discussion 336-328.
40. Sayer G, Naka Y, Jorde UP. Ventricular assist device therapy. Cardiovasc Ther 2009;27:140-150.
41. Pal JD, Klodell CT, John R, Pagani FD, Rogers JG, Farrar DJ, Milano CA. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. Circulation 2009;120(Suppl. 11): S215-S219.
42. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, Struber M. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357-361.
43. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-321.
44. Holman WA, Kirklin JK. Outcomes after mechanical circulatory support. In: Frazier OH, Kirklin JK (eds), ISHLT Monograph Series. 2006. p137-154.
45. Holman WL, Pae WE, Teutenberg JJ, Acker MA, Naftel DC, Sun BC, Milano CA, Kirklin JK. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208:755-761. Discussion 761-752.
46. Goldstein DJ. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 2003;108(Suppl. 1): II272-II277. (Pubitemid 37099967)
47. Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009;28:733-735.
48. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005;45:1428-1434. (Pubitemid 40615614)
49. Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 1994;24:1688-1691. (Pubitemid 24369194)
50. Haj-Yahia S, Birks EJ, Rogers P, Bowles C, Hipkins M, George R, Amrani M, Petrou M, Pepper J, Dreyfus G, Khaghani A. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 2007;134:199-203. (Pubitemid 46962007)
51. Feller ED, Sorensen EN, Haddad M, Pierson RN 3rd, Johnson FL, Brown JM, Griffith BP. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg 2007;83:1082-1088. (Pubitemid 46328825)
52. Siegenthaler MP, Martin J, Pernice K, Doenst T, Sorg S, Trummer G, Friesewinkel O, Beyersdorf F. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 2003;23:748-754. Discussion 754-745.
53. Schulman AR, Martens TP, Christos PJ, Russo MJ, Comas GM, Cheema FH, Naseem TM, Wang R, Idrissi KA, Bailey SH, Naka Y. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J Thorac Cardiovasc Surg 2007;133:841-842. (Pubitemid 46274760)
54. Siegenthaler MP, Westaby S, Frazier OH, Martin J, Banning A, Robson D, Pepper J, Poole-Wilson P, Beyersdorf F. Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J 2005;26:1031-1038. (Pubitemid 40695034)
55. Birks EJ. Left ventricular assist devices. Heart 2010;96:63-71.
56. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, Rose E, Holman W, Furukawa S, Frazier OH, Dembitsky W. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17. (Pubitemid 40038090)
57. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, Delgado R, Frazier OH. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005;11:133-138.
58. Miller LW. Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg 2003;75(Suppl. 6): S66-S71. (Pubitemid 36681536)
59. Loebe M, Koerner MM, Lafuente JA, Noon GP. Patient selection for assist devices: bridge to transplant. Curr Opin Cardiol 2003;18:141-146.
60. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006;25:756-764. (Pubitemid 43963371)
61. Lietz K, Miller LW. Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009;24:246-251.
62. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995;92(Suppl. 9): II169-II173.
63. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003;125:855-862. (Pubitemid 36457507)
64. Fitzpatrick JR 3rd, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008;27:1286-1292.
65. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008;51:2163-2172. (Pubitemid 351713685)
66. Potapov EV, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y, Hennig F, Krabatsch T, Hetzer R. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 2008;27:1275-1281.
67. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, Cleeton T, Koenig SC, Edwards L, Kirklin JK. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009;28:44-50.
68. Klotz S, Vahlhaus C, Riehl C, Reitz C, Sindermann JR, Scheld HH. Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant 2010;29:45-52.
69. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006;25:1-6. (Pubitemid 43049657)
70. Farrar DJ. Preoperative predictors of survival in patients with thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994;13:93-100. Discussion 100-101.
71. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999;68:2181-2184. (Pubitemid 30027846)
72. Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, Naka Y. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002;73:745-750. (Pubitemid 34188307)
73. Kormos RL, Gasior TA, Kawai A, Pham SM, Murali S, Hattler BG, Griffith BP. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996;111:773-782. Discussion 782-773.
74. Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation 1996;94(Suppl. 9): II216-II221. (Pubitemid 26363395)
75. Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004;77:859-863. (Pubitemid 38271049)
76. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, Hsu AP, Yeager ML, Buda T, Hoercher KJ, Howard MW, Takagaki M, Doi K, Fukamachi K. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002;106(Suppl. 121): I198-I202.
77. Puwanant S, Hamilton KK, Klodell CT, Hill JA, Schofield RS, Cleeton TS, Pauly DF, Aranda JM Jr. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 2008;27:1102-1107.
78. Santambrogio L, Bianchi T, Fuardo M, Gazzoli F, Veronesi R, Braschi A, Maurelli M. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg 2006;5:379-382. (Pubitemid 44166439)
79. Scalia GM, McCarthy PM, Savage RM, Smedira NG, Thomas JD. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr 2000;13:754-763. (Pubitemid 30651141)
80. Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichart B, Vitali E, Pavie A, Mesana T, Loisance DY, Wheeldon DR, Portner PM. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001;103:231-237. (Pubitemid 32095408)
81. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009;28:827-833.
82. Butler J, Geisberg C, Howser R, Portner PM, Rogers JG, Deng MC, Pierson RN 3rd. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg 2006;81:1745-1751. (Pubitemid 350030010)
83. McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, Young JB. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-912. (Pubitemid 28196603)
84. Reedy JE, Swartz MT, Termuhlen DF, Pennington DG, McBride LR, Miller LW, Ruzevich SA. Bridge to heart transplantation: importance of patient selection. J Heart Transplant 1990;9:473-480. Discussion 480-471.
85. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Grimm M, Wolner E, Wieselthaler GM. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072-1078.
86. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Zuckermann AO, Wieselthaler GM. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant 2009;28:367-372.
87. Matthews JC, Dardas TF, Koelling TM, Pagani FD, Aaronson KD. LVAD risk prediction models: the value of getting another opinion. (Abstract 400). J Heart Lung Transplant 2008;27:S205.
88. Brewer RJ, Morgan JA, Nemeh H, Williams C, Czerska B, Tita C, Drost C, Smith C, Chernich J, Lanfear D. Persistent right ventricular failure after LVAD implantation for bridge-to-transplant does not reduce survival to transplantation. J Card Fail 2009;15:S47.
89. Patrick JE, Miller LW, Boyce SW. Improved survival with simultaneous RVAD placement in LVAD recipients at high risk for RV failure. J Heart Lung Transplant 2009;28:S209.
90. Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, Laporte CM, O'Hara ML, Howell E, Dougherty D, Cohen JE, Southerland KW, Howard JL, Paulson EC, Acker MA, Morris RJ, Woo YJ. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 2009;137:971-977.
91. Hill JD, Farrar DJ, Naka Y, Chen JM, Portner PM, Loisance D. Positive displacement ventricular assist devices. In: Frazier O, Kirklin J (eds), ISHLT Monograph Series 1, Mechanical Circulatory Support. Elsevier Inc; 2006. p53-75.
92. Farrar DJ, Hill JD, Pennington DG, McBride LR, Holman WL, Kormos RL, Esmore D, Gray LA Jr, Seifert PE, Schoettle GP, Moore CH, Hendry PJ, Bhayana JN. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-209. (Pubitemid 27034359)
93. INTERMACS. http://www.uab.edu/ctsresearch/intermacs/presentations-part2. htm (14 September 2009).
94. Kormos RL, Teuteberg J, Russell SD, Massey T, Feldman D, Moazami N, Farrar C, Milano C. Right ventricular failure (RVF) in patients with continuous flow left ventricular assist devices (LVAD). (Abstract 203). J Heart Lung Transplant 2008;27:S134.
95. Mokadam NA, Ewald GA, Damiano RJ Jr, Moazami N. Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg 2006;131:925-926.
96. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg 2003;237:631-636. Discussion 636-637.
97. Stevenson LW. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Circulation 2003;108:492-497. (Pubitemid 36935545)
98. Upadya S, Lee FA, Saldarriaga C, Verma S, Sedrakyan A, Nystrom K, Katz SD. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. J Heart Lung Transplant 2004;23:466-472. (Pubitemid 38452699)
99. Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail 2007;13:417-421. (Pubitemid 47176926)
100. Morgan JA, John R, Rao V, Weinberg AD, Lee BJ, Mazzeo PA, Flannery MR, Chen JM, Oz MC, Naka Y. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg 2004;127:1309-1316. (Pubitemid 38560592)
101. Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002;39:1247-1254. (Pubitemid 34297861)
102. Bank AJ, Mir SH, Nguyen DQ, Bolman RM 3rd, Shumway SJ, Miller LW, Kaiser DR, Ormaza SM, Park SJ. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 2000;69:1369-1374. Discussion 1375.
103. Bhat G. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy. ASAIO J 2006;52:677-681. (Pubitemid 44784570)
104. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963. (Pubitemid 24000804)